0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sexually Transmitted Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-28F14115
Home | Market Reports | Health| Reproductive Health
Global Sexually Transmitted Disease Testing Market Research Report 2023
BUY CHAPTERS

Sexually Transmitted Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28F14115
Report
December 2024
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sexually Transmitted Disease Testing - Market Size

The global market for Sexually Transmitted Disease Testing was estimated to be worth US$ 9600 million in 2023 and is forecast to a readjusted size of US$ 15220 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

Sexually Transmitted Disease Testing - Market

Sexually Transmitted Disease Testing - Market

Sexually Transmitted Disease (STD) testing is a medical procedure carried out to detect the presence of infections that are transmitted through sexual contact. STDs can be caused by bacteria, viruses, parasites, or fungi and can be asymptomatic or present symptoms such as genital sores, abnormal discharge, pain, itching, or burning sensation.Sexually Transmitted Disease Testing is used to find out if you have been infected with an STD. Testing can help you get the treatment you need and may help prevent the spread of disease.STD testing typically involves collecting samples like blood, urine, swabs from genital areas, or mouth/throat for laboratory analysis.
The global sexually transmitted disease (STD) testing market refers to the market for diagnostic tests used to identify and diagnose sexually transmitted infections. This includes tests for a wide range of STDs such as HIV, chlamydia, gonorrhea, syphilis, herpes, HPV (human papillomavirus), and others.
The STD testing market has experienced significant growth in recent years due to several factors, including:
Increasing prevalence of STDs: The global burden of STDs remains high, with millions of new infections reported every year. This has led to an increased demand for testing and diagnosis.
Growing awareness and education: Public awareness campaigns, initiatives by healthcare organizations, and educational programs have helped raise awareness about the importance of STD testing, leading to more individuals seeking testing services.
Technological advancements: Advances in diagnostic technologies have made it easier and faster to detect STDs. For instance, molecular testing methods such as Polymerase Chain Reaction (PCR) have improved the sensitivity and specificity of STD testing.
Expanding healthcare infrastructure: Improvements in healthcare infrastructure, especially in developing countries, have facilitated access to STD testing services.
The global STD testing market is characterized by the presence of several market players, including diagnostic laboratories, hospitals, and specialized testing centers. These entities offer a range of testing methods, from traditional laboratory-based tests to point-of-care testing kits.
The market is also influenced by government initiatives, policies, and regulations related to STD prevention and control. Additionally, the integration of STD testing services with other healthcare settings, such as primary care clinics and sexual health clinics, has contributed to the market’s growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Disease Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sexually Transmitted Disease Testing by region & country, by Type, and by Application.
The Sexually Transmitted Disease Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Disease Testing.
Market Segmentation

Scope of Sexually Transmitted Disease Testing - Market Report

Report Metric Details
Report Name Sexually Transmitted Disease Testing - Market
Forecasted market size in 2030 US$ 15220 million
CAGR 6.9%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories, bioMerieux S.A., Danaher Corporation, DiaSorin, Hologic, OraSure Technologies, Qiagen, Roche Holdings AG, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sexually Transmitted Disease Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Sexually Transmitted Disease Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Sexually Transmitted Disease Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sexually Transmitted Disease Testing - Market size in 2030?

Ans: The Sexually Transmitted Disease Testing - Market size in 2030 will be US$ 15220 million.

Who are the main players in the Sexually Transmitted Disease Testing - Market report?

Ans: The main players in the Sexually Transmitted Disease Testing - Market are Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories, bioMerieux S.A., Danaher Corporation, DiaSorin, Hologic, OraSure Technologies, Qiagen, Roche Holdings AG, Thermo Fisher Scientific

What are the Application segmentation covered in the Sexually Transmitted Disease Testing - Market report?

Ans: The Applications covered in the Sexually Transmitted Disease Testing - Market report are Laboratory Testing, Point-of-Care (POC) Testing, Others

What are the Type segmentation covered in the Sexually Transmitted Disease Testing - Market report?

Ans: The Types covered in the Sexually Transmitted Disease Testing - Market report are Blood Testing, Urine Testing, Swab Testing

Recommended Reports

STD Testing & Diagnosis

Individual STD Types

Infectious Disease Testing

1 Market Overview
1.1 Sexually Transmitted Disease Testing Product Introduction
1.2 Global Sexually Transmitted Disease Testing Market Size Forecast
1.3 Sexually Transmitted Disease Testing Market Trends & Drivers
1.3.1 Sexually Transmitted Disease Testing Industry Trends
1.3.2 Sexually Transmitted Disease Testing Market Drivers & Opportunity
1.3.3 Sexually Transmitted Disease Testing Market Challenges
1.3.4 Sexually Transmitted Disease Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sexually Transmitted Disease Testing Players Revenue Ranking (2023)
2.2 Global Sexually Transmitted Disease Testing Revenue by Company (2019-2024)
2.3 Key Companies Sexually Transmitted Disease Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sexually Transmitted Disease Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Sexually Transmitted Disease Testing
2.6 Sexually Transmitted Disease Testing Market Competitive Analysis
2.6.1 Sexually Transmitted Disease Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sexually Transmitted Disease Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Blood Testing
3.1.2 Urine Testing
3.1.3 Swab Testing
3.2 Global Sexually Transmitted Disease Testing Sales Value by Type
3.2.1 Global Sexually Transmitted Disease Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sexually Transmitted Disease Testing Sales Value, by Type (2019-2030)
3.2.3 Global Sexually Transmitted Disease Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory Testing
4.1.2 Point-of-Care (POC) Testing
4.1.3 Others
4.2 Global Sexually Transmitted Disease Testing Sales Value by Application
4.2.1 Global Sexually Transmitted Disease Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sexually Transmitted Disease Testing Sales Value, by Application (2019-2030)
4.2.3 Global Sexually Transmitted Disease Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sexually Transmitted Disease Testing Sales Value by Region
5.1.1 Global Sexually Transmitted Disease Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sexually Transmitted Disease Testing Sales Value by Region (2019-2024)
5.1.3 Global Sexually Transmitted Disease Testing Sales Value by Region (2025-2030)
5.1.4 Global Sexually Transmitted Disease Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sexually Transmitted Disease Testing Sales Value, 2019-2030
5.2.2 North America Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sexually Transmitted Disease Testing Sales Value, 2019-2030
5.3.2 Europe Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sexually Transmitted Disease Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sexually Transmitted Disease Testing Sales Value, 2019-2030
5.5.2 South America Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sexually Transmitted Disease Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sexually Transmitted Disease Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sexually Transmitted Disease Testing Sales Value
6.3 United States
6.3.1 United States Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.3.2 United States Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.4.2 Europe Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.5.2 China Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.6.2 Japan Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.7.2 South Korea Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sexually Transmitted Disease Testing Sales Value, 2019-2030
6.9.2 India Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sexually Transmitted Disease Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Sexually Transmitted Disease Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Becton Dickinson and Company
7.2.1 Becton Dickinson and Company Profile
7.2.2 Becton Dickinson and Company Main Business
7.2.3 Becton Dickinson and Company Sexually Transmitted Disease Testing Products, Services and Solutions
7.2.4 Becton Dickinson and Company Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Becton Dickinson and Company Recent Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Profile
7.3.2 Bio-Rad Laboratories Main Business
7.3.3 Bio-Rad Laboratories Sexually Transmitted Disease Testing Products, Services and Solutions
7.3.4 Bio-Rad Laboratories Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.3.5 bioMerieux S.A. Recent Developments
7.4 bioMerieux S.A.
7.4.1 bioMerieux S.A. Profile
7.4.2 bioMerieux S.A. Main Business
7.4.3 bioMerieux S.A. Sexually Transmitted Disease Testing Products, Services and Solutions
7.4.4 bioMerieux S.A. Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.4.5 bioMerieux S.A. Recent Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Profile
7.5.2 Danaher Corporation Main Business
7.5.3 Danaher Corporation Sexually Transmitted Disease Testing Products, Services and Solutions
7.5.4 Danaher Corporation Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Corporation Recent Developments
7.6 DiaSorin
7.6.1 DiaSorin Profile
7.6.2 DiaSorin Main Business
7.6.3 DiaSorin Sexually Transmitted Disease Testing Products, Services and Solutions
7.6.4 DiaSorin Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.6.5 DiaSorin Recent Developments
7.7 Hologic
7.7.1 Hologic Profile
7.7.2 Hologic Main Business
7.7.3 Hologic Sexually Transmitted Disease Testing Products, Services and Solutions
7.7.4 Hologic Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Hologic Recent Developments
7.8 OraSure Technologies
7.8.1 OraSure Technologies Profile
7.8.2 OraSure Technologies Main Business
7.8.3 OraSure Technologies Sexually Transmitted Disease Testing Products, Services and Solutions
7.8.4 OraSure Technologies Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.8.5 OraSure Technologies Recent Developments
7.9 Qiagen
7.9.1 Qiagen Profile
7.9.2 Qiagen Main Business
7.9.3 Qiagen Sexually Transmitted Disease Testing Products, Services and Solutions
7.9.4 Qiagen Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Qiagen Recent Developments
7.10 Roche Holdings AG
7.10.1 Roche Holdings AG Profile
7.10.2 Roche Holdings AG Main Business
7.10.3 Roche Holdings AG Sexually Transmitted Disease Testing Products, Services and Solutions
7.10.4 Roche Holdings AG Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Roche Holdings AG Recent Developments
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Profile
7.11.2 Thermo Fisher Scientific Main Business
7.11.3 Thermo Fisher Scientific Sexually Transmitted Disease Testing Products, Services and Solutions
7.11.4 Thermo Fisher Scientific Sexually Transmitted Disease Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Thermo Fisher Scientific Recent Developments
8 Industry Chain Analysis
8.1 Sexually Transmitted Disease Testing Industrial Chain
8.2 Sexually Transmitted Disease Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sexually Transmitted Disease Testing Sales Model
8.5.2 Sales Channel
8.5.3 Sexually Transmitted Disease Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sexually Transmitted Disease Testing Market Trends
    Table 2. Sexually Transmitted Disease Testing Market Drivers & Opportunity
    Table 3. Sexually Transmitted Disease Testing Market Challenges
    Table 4. Sexually Transmitted Disease Testing Market Restraints
    Table 5. Global Sexually Transmitted Disease Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sexually Transmitted Disease Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Sexually Transmitted Disease Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Sexually Transmitted Disease Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Sexually Transmitted Disease Testing
    Table 10. Global Sexually Transmitted Disease Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Sexually Transmitted Disease Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Sexually Transmitted Disease Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Sexually Transmitted Disease Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Sexually Transmitted Disease Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Sexually Transmitted Disease Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Sexually Transmitted Disease Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Sexually Transmitted Disease Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Sexually Transmitted Disease Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Sexually Transmitted Disease Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Sexually Transmitted Disease Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Sexually Transmitted Disease Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Sexually Transmitted Disease Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Sexually Transmitted Disease Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Sexually Transmitted Disease Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Sexually Transmitted Disease Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Sexually Transmitted Disease Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Sexually Transmitted Disease Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Sexually Transmitted Disease Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Becton Dickinson and Company Basic Information List
    Table 37. Becton Dickinson and Company Description and Business Overview
    Table 38. Becton Dickinson and Company Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Becton Dickinson and Company (2019-2024)
    Table 40. Becton Dickinson and Company Recent Developments
    Table 41. Bio-Rad Laboratories Basic Information List
    Table 42. Bio-Rad Laboratories Description and Business Overview
    Table 43. Bio-Rad Laboratories Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Bio-Rad Laboratories (2019-2024)
    Table 45. Bio-Rad Laboratories Recent Developments
    Table 46. bioMerieux S.A. Basic Information List
    Table 47. bioMerieux S.A. Description and Business Overview
    Table 48. bioMerieux S.A. Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of bioMerieux S.A. (2019-2024)
    Table 50. bioMerieux S.A. Recent Developments
    Table 51. Danaher Corporation Basic Information List
    Table 52. Danaher Corporation Description and Business Overview
    Table 53. Danaher Corporation Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Danaher Corporation (2019-2024)
    Table 55. Danaher Corporation Recent Developments
    Table 56. DiaSorin Basic Information List
    Table 57. DiaSorin Description and Business Overview
    Table 58. DiaSorin Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of DiaSorin (2019-2024)
    Table 60. DiaSorin Recent Developments
    Table 61. Hologic Basic Information List
    Table 62. Hologic Description and Business Overview
    Table 63. Hologic Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Hologic (2019-2024)
    Table 65. Hologic Recent Developments
    Table 66. OraSure Technologies Basic Information List
    Table 67. OraSure Technologies Description and Business Overview
    Table 68. OraSure Technologies Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of OraSure Technologies (2019-2024)
    Table 70. OraSure Technologies Recent Developments
    Table 71. Qiagen Basic Information List
    Table 72. Qiagen Description and Business Overview
    Table 73. Qiagen Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Qiagen (2019-2024)
    Table 75. Qiagen Recent Developments
    Table 76. Roche Holdings AG Basic Information List
    Table 77. Roche Holdings AG Description and Business Overview
    Table 78. Roche Holdings AG Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Roche Holdings AG (2019-2024)
    Table 80. Roche Holdings AG Recent Developments
    Table 81. Thermo Fisher Scientific Basic Information List
    Table 82. Thermo Fisher Scientific Description and Business Overview
    Table 83. Thermo Fisher Scientific Sexually Transmitted Disease Testing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Sexually Transmitted Disease Testing Business of Thermo Fisher Scientific (2019-2024)
    Table 85. Thermo Fisher Scientific Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Sexually Transmitted Disease Testing Downstream Customers
    Table 89. Sexually Transmitted Disease Testing Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Sexually Transmitted Disease Testing Product Picture
    Figure 2. Global Sexually Transmitted Disease Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sexually Transmitted Disease Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Sexually Transmitted Disease Testing Report Years Considered
    Figure 5. Global Sexually Transmitted Disease Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Sexually Transmitted Disease Testing Revenue in 2023
    Figure 7. Sexually Transmitted Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Blood Testing Picture
    Figure 9. Urine Testing Picture
    Figure 10. Swab Testing Picture
    Figure 11. Global Sexually Transmitted Disease Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Sexually Transmitted Disease Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Laboratory Testing
    Figure 14. Product Picture of Point-of-Care (POC) Testing
    Figure 15. Product Picture of Others
    Figure 16. Global Sexually Transmitted Disease Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Sexually Transmitted Disease Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Sexually Transmitted Disease Testing Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Sexually Transmitted Disease Testing Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Sexually Transmitted Disease Testing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Sexually Transmitted Disease Testing Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Sexually Transmitted Disease Testing Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Sexually Transmitted Disease Testing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Sexually Transmitted Disease Testing Sales Value (%), (2019-2030)
    Figure 29. United States Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Sexually Transmitted Disease Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Sexually Transmitted Disease Testing Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Sexually Transmitted Disease Testing Sales Value by Application (%), 2023 VS 2030
    Figure 50. Sexually Transmitted Disease Testing Industrial Chain
    Figure 51. Sexually Transmitted Disease Testing Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS